To evaluate the efficacy of Cognitive Behavioral Immersion (CBI) accessed via VR headset compared to flat-screen device and a delayed access control group in participants with elevated depression symptoms.
Approach:
Study Design: A 3-arm randomized controlled trial comparing CBI-VR, CBI-FS, and a delayed access control (DAC) group.
Key Findings:
The study addresses the depression-treatment paradox by exploring scalable and accessible mental health interventions.
Preliminary findings supported CBI's feasibility and potential for reducing depressive symptoms.
Interpretation:
The study aims to rigorously test the efficacy of CBI in different delivery formats.
Limitations:
Efficacy of CBI has not been rigorously tested prior to this study.
Potential learning curve associated with VR technology for participants.
Conclusion:
The study aims to provide insights into the effectiveness of immersive VR versus traditional methods for delivering CBT to treat depression.
